TY - JOUR T1 - Developing future leaders in evidence-based medicine: the inaugural David Sackett Fellowship JF - BMJ Evidence-Based Medicine JO - BMJ EBM SP - 131 LP - 132 DO - 10.1136/bmjebm-2022-111996 VL - 27 IS - 3 AU - Peter J Gill AU - Braden O’Neil AU - Georgia C Richards Y1 - 2022/06/01 UR - http://ebm.bmj.com/content/27/3/131.abstract N2 - David L Sackett, widely described as the ‘father of evidence-based medicine (EBM)’1 was a transformative figure in 20th century health research and education. His career spanned three distinct phases: as a clinician, as a clinical trialist and as a clinical epidemiologist, most of it at McMaster University in Hamilton, Ontario, Canada, where he was the founder (in 1967, at the age of 32) of the Department of Clinical Epidemiology and Biostatistics. That department remained his professional home until 1994 when he moved to the University of Oxford for 5 years to found the Centre for Evidence-Based Medicine (CEBM).David was an extraordinary mentor to junior physicians and scientists. He exemplified an uncommon personal commitment to life-long learning, including returning to residency at 49 years of age to complete 2 years of training in internal medicine, after which he became Physician-in-Chief at the McMaster University Medical Centre. An unsurpassed teacher and advocate of clear writing, David retired from clinical practice in 1999 to research, write and teach the next generation about randomised clinical trials, alongside his wife Barbara Sackett, an exceptional scholar herself. Sackett left a legacy in myriad areas of health research, including but not limited to the management of long-term conditions, treatment adherence and novel approaches to conducting randomised controlled trials; he also left a lasting legacy of mentorship and inspired many leaders in EBM.The EBMLive Conference (https://ebmlive.org/) is a global initiative … ER -